"Using lithium metal cathode material, the energy density is three times higher than that of batteries currently on the market, and the charging speed is doubled."
This is actually a technology that Blue Star already has, but this technical route has not been overcome due to various difficulties and has only been living in the laboratory.
For example, lithium metal will expand due to charging and discharging, destroying the battery structure. Lithium metal and mainstream solid electrolyte materials are poor and may explode.
This lithium battery technology is not a mature technology of the Mage Alliance, but was improved by Zheng Li based on Blue Star's immature technology.
The energy system of the Mage Alliance is not lithium battery at all. They mainly rely on bioenergy and use a small amount of solid high-energy fuel.
The Mage Alliance has a system theory on the construction of chemical materials, and their development in computational chemistry is far away from Blue Star.
Zheng Li calculated the structure of lithium metal through the biocloud and analyzed the lithium metal cathode structure that best meets the requirements for large-scale commercialization.
At the same time, a new graphene structural coating is introduced as an intermediate to prevent the lithium electrode from reacting directly with the solid electrolyte.
All the executives present were shocked because they had never heard that Zheng Li knew anything about lithium batteries.
"Director Zheng, can this technology be implemented on a large scale? Or is it just a laboratory product?" Cheng Gang asked a question that went straight to the core.
Laboratory products are a long way from being commercially available.
The most important point of commercial products is cost.
The cost here is not only the manufacturing cost, but also the labor cost.
Like the first product of Kechuang Biotech, the manufacturing cost of endorphins is not high, but the labor cost is high.
Skilled workers for large-scale industrial production of endorphins need to be trained for at least half a year to achieve a 95% yield rate.
After hearing this, Cheng Gang's first reaction was that the lithium metal electrode with a completely new structure should not have to be arranged atoms one by one to form a special structure.
If you do this, there is no way to use it commercially on a large scale.
The cost is too high.
Zheng Li: "The cost of laboratory manufacturing is about twice that of ordinary lithium battery cathode materials. If large-scale industrial production is carried out, the cost can be reduced."
"And I also plan to license the lithium metal cathode through patent licensing. We will not produce it directly."
In recent years, the new energy industry chain has been in full swing. Basically, the share prices of upstream and downstream companies in the new energy industry chain have at least doubled.
2022 is not as hot as 2021, but the stock prices of new energy companies with good quality are still rising.
However, some companies that built new production capacity but could not find buyers for the new production capacity saw their stock prices fluctuate at high levels and then fell.
Because the industry's production capacity expanded too much in 20 and 21, not all production capacity can be absorbed. Those who exploded first will eat meat, and those who exploded later will be beaten.
Once Kechuang Biotech’s lithium battery technology is announced, all companies making positive electrode materials will be beaten.
One or two lower limits will definitely make it impossible to stop.
Cheng Gang is overjoyed. This is the biggest benefit to the company. The lithium battery that can triple the capacity means that electric vehicles can truly compete with gasoline vehicles.
By 2025, Huaguo’s goal is a penetration rate of 20%. Cheng Gang is certain that Kechuang Biotechnology’s lithium battery technology can double this penetration rate.
Penetration rate refers to the market share of electric vehicles. The target of 20% is actually not high at all.
The bill signed by Amerikan stipulates that the penetration rate of electric vehicles in the United States should reach 50% by 2030.
Cheng Gang was relieved in his heart. He finally found a place to make up for the huge losses he had made by investing in Abbot Biotech and Si Microorganisms.
Although executives of listed companies cannot engage in related party transactions, if they want to purchase their own company's stocks, they must make an announcement in advance.
Relatives of executives of listed companies are also prohibited from illegal purchases. For example, if a relative buys shares of Science and Technology Biotechnology in the first leg, and then the back leg turns out to be good, this will definitely be investigated by the China Securities Regulatory Commission.
But this is just theory, there are many ways to operate. For example, you can sign an agreement with a private equity company and let them purchase it on your behalf, and the proceeds from the purchase will be divided into dividends according to a certain proportion.
There are many ways to do it.
And you don’t necessarily need to buy shares of Kechuang Biotech.
With such a big technological breakthrough in lithium batteries, companies related to new energy vehicles will definitely see a surge.
You only need to increase leverage to buy stocks of new energy vehicle companies.
Cheng Gang was thinking about what to do.
Zheng Li continued in the video conference: "Lithium battery technology patent authorization is only authorized to Chinese car companies."
"Foreign car companies and joint venture car companies will not be considered. The specific operation methods and external rhetoric need to be thought of by you."
"Including our brain-computer connection VR, we can use new battery technology."
“The authorization of lithium cathode technology to mobile phone manufacturers is not subject to this restriction.”
The executives present were puzzled, but no one asked questions in public.
Because of sensitive issues like this, the executives of Kechuang Biotechnology entrusted Li Miaomiao to ask Zheng Li, and then Li Miaomiao judged whether he could reveal the reasons for Zheng Li's actions to the senior officials.
As for why this tradition was formed, maybe it was because when an executive asked a question, Zheng Li moved on to the next agenda as if he didn't hear it.
It's a bit embarrassing to be treated like a jerk in an executive meeting by your biggest boss.
"Entrust a lawyer to register the patent as soon as possible. The news can be spread. I will send the samples back, and the samples can be tested by domestic car manufacturers."
"Only I know the specific structure and manufacturing method of the lithium metal cathode, and there is no leakage."
After the meeting, all the executives were cheered. Affected by this good news, it would not be a problem for Kechuang Biotech's stock price to double.
Super battery technology will be used in all new energy vehicles in China in the future. The unit price of the vehicle is much more expensive than that of a mobile phone, and the patent licensing fee that can be charged is also much higher than that of a mobile phone.
The executives chatted privately after the board meeting and said:
"The patent licensing fee for brain-computer connection with mobile phones is two hundred, and the patent licensing fee for super batteries is two thousand, so it's not too much."
"Two thousand? The situation is too small. Do you know how much the CATL patent lawsuit requires the other party to compensate?"
"How many?"
"Twenty-four percent of the total profit on this product, multiplied by ten percent."
"It's equivalent to 2.4% of the total profit, which is not very high."
"The problem is that this manufacturer's products only infringe a very small part of CATL's patents, and they do not use CATL's patents from beginning to end. They have to pay nearly 100 million yuan."
"No one else can steal our patents even if they want to."
"Who said that endorphins were stolen by Asan? I just said that patents should not be licensed to foreign pharmaceutical companies. Data from this year's semi-annual report shows that endorphins account for more than 20% worldwide. From Asan.”
"The problem is that Asan doesn't know how to pay the patent licensing fee. The court that comes to Asan will not accept your lawsuit at all."
